New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions

HMN 2024 – A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heart attacks and stroke in certain patients, the study says. The FDA’s ruling […]

Read More – HMN 2024